This post was originally published on this site
Teva ADR announced earnings per share of $0.59 on revenue of $3.6B. Analysts polled by Investing.com anticipated EPS of $0.62 on revenue of $3.85B.
Teva ADR shares are down 39.61% from the beginning of the year, still down 22.75% from its 52 week high of $11.34 set on August 11.
Teva ADR shares lost 4.68% in pre-market trade following the report.
Teva ADR’s report follows an earnings beat by UnitedHealth on October 14, who reported EPS of $5.79 on revenue of $80.9B, compared to forecasts EPS of $5.43 on revenue of $80.52B.
J&J had beat expectations on October 18 with third quarter EPS of $2.55 on revenue of $23.79B, compared to forecast for EPS of $2.52 on revenue of $23.46B.
Stay up-to-date on all of the upcoming earnings reports by visiting Investing.com’s earnings calendar
